CSX CORP
CSXNASDAQ🏆 #146 by market capEarnings Jan 20 · PostUS Equity
$51.98▼ $0.29 (−0.55%)
🌙 After hours$52.89▲ 1.75%Regular close · extended-hours price shownTrack CSX
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▲ 7.6%
14d▲ 7.6%
30d▲ 11.1%
ytd▲ 43.3%
1y▲ 45.7%
🏦Market Cap
$95.82B
Mid Cap
📈Revenue Growth (YoY)
5.8%
Slowing
📊Gross Margin
71.6%
High
💵FCF Margin
21.5%
Strong
⚖️P/S Ratio
6.3x
Fair
Otter Score
80
Strong
CSX CORP
CSXAnalyst Ratings
Price
$51.98
Total
46
Raised
2
Lowered
6
Avg PT
$52.47
H / L
$60 / $32
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Susquehanna | Reiterated | Positive | 2026-10-27 | $58.00 | +11.60% |
Citigroup | Reiterated | Neutral | 2026-10-23 | $41.00 | −21.10% |
UBS | Reiterated | Buy | 2026-10-22 | $54.00 | +3.90% |
JP Morgan | Reiterated | Overweight | 2026-10-22 | $40.00 | −23.00% |
TD Cowen | Reiterated | Buy | 2026-10-22 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-22 | $53.00 | +2.00% |
B of A Securities | Reiterated | Buy | 2026-10-22 | — | — |
Barclays | Reiterated | Overweight | 2026-07-23 | $60.00 | +15.40% |
Evercore ISI Group | Reiterated | In Line | 2026-07-23 | — | — |
BMO Capital | Reiterated | Market Perform | 2026-07-23 | $52.00 | +0.00% |
Benchmark | Reiterated | Buy | 2026-07-15 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-07-08 | $53.00 | +2.00% |
Baird | Reiterated | Outperform | 2026-07-07 | — | — |
Morgan Stanley | Reiterated | Underweight | 2026-07-06 | $32.00 | −38.40% |
Goldman Sachs | Reiterated | Neutral | 2026-04-23 | $41.00 | −21.10% |
Bernstein | Reiterated | Market Perform | 2026-03-31 | $49.00 | −5.70% |
Jefferies | Reiterated | Buy | 2025-10-17 | $42.00 | −19.20% |
Raymond James | Reiterated | Outperform | 2025-10-17 | $55.00 | +5.80% |
Stifel | Reiterated | Buy | 2025-04-17 | — | — |
Loop Capital | Downgraded | Buy → Hold | 2025-02-03 | — | — |
Stephens & Co. | Reiterated | Overweight | 2025-01-24 | — | — |
Argus Research | Reiterated | Buy | 2023-07-25 | $56.00 | +7.70% |
Credit Suisse | Reiterated | Outperform | 2023-04-21 | $37.00 | −28.80% |
Cowen & Co. | Reiterated | Market Perform | 2023-01-26 | $37.00 | −28.80% |
Deutsche Bank | Reiterated | Buy | 2022-11-29 | $59.00 | +13.50% |
TD Securities | Downgraded | Buy → Hold | 2022-04-18 | — | — |
Atlantic Equities | Upgraded | Neutral → Overweight | 2020-09-23 | — | — |
CFRA | Reiterated | Buy | 2020-04-23 | — | — |
Bank of America | Reiterated | Buy | 2019-10-17 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2019-03-06 | $54.00 | +3.90% |
Argus | Upgraded | Hold → Buy | 2018-05-05 | — | — |
Scotiabank | Downgraded | Sector Outperform → Sector Perform | 2018-01-12 | — | — |
Avondale Partners | Reiterated | Market Outperform → Outperform | 2017-02-10 | — | — |
Aegis Capital | Reiterated | Hold | 2016-10-24 | — | — |
Seaport Global | Reiterated | Neutral | 2016-10-19 | — | — |
BB&T Capital | Downgraded | Buy → Hold | 2016-07-15 | — | — |
Oppenheimer | Reiterated | Market Perform → Perform | 2016-06-16 | — | — |
CLSA | Reiterated | Underperform | 2016-05-19 | — | — |
Buckingham Research | Reiterated | Buy | 2016-01-14 | — | — |
Nomura | Reiterated | Buy | 2016-01-14 | — | — |
Topeka | Reiterated | Hold | 2015-07-10 | — | — |
Macquarie | Reiterated | Neutral | 2014-08-12 | — | — |
FBR Capital | Reiterated | Outperform | 2014-06-24 | — | — |
Deutsche bank | Downgraded | Buy → Hold | 2012-10-18 | $59.00 | +13.50% |
Sterne Agee | Reiterated | Buy | 2012-04-19 | — | — |
Bank oferica | Reiterated | Buy | 2012-03-15 | — | — |
Institution
Susquehanna
Reiterated · Positive · 2026-10-27
$58.00
+11.60%
Citigroup
Reiterated · Neutral · 2026-10-23
$41.00
−21.10%
UBS
Reiterated · Buy · 2026-10-22
$54.00
+3.90%
JP Morgan
Reiterated · Overweight · 2026-10-22
$40.00
−23.00%
TD Cowen
Reiterated · Buy · 2026-10-22
—
—
RBC Capital
Reiterated · Outperform · 2026-10-22
$53.00
+2.00%
B of A Securities
Reiterated · Buy · 2026-10-22
—
—
Barclays
Reiterated · Overweight · 2026-07-23
$60.00
+15.40%
Evercore ISI Group
Reiterated · In Line · 2026-07-23
—
—
BMO Capital
Reiterated · Market Perform · 2026-07-23
$52.00
+0.00%
Benchmark
Reiterated · Buy · 2026-07-15
—
—
Wells Fargo
Reiterated · Overweight · 2026-07-08
$53.00
+2.00%
Baird
Reiterated · Outperform · 2026-07-07
—
—
Morgan Stanley
Reiterated · Underweight · 2026-07-06
$32.00
−38.40%
Goldman Sachs
Reiterated · Neutral · 2026-04-23
$41.00
−21.10%
Bernstein
Reiterated · Market Perform · 2026-03-31
$49.00
−5.70%
Jefferies
Reiterated · Buy · 2025-10-17
$42.00
−19.20%
Raymond James
Reiterated · Outperform · 2025-10-17
$55.00
+5.80%
Stifel
Reiterated · Buy · 2025-04-17
—
—
Loop Capital
Downgraded · Buy → Hold · 2025-02-03
—
—
Stephens & Co.
Reiterated · Overweight · 2025-01-24
—
—
Argus Research
Reiterated · Buy · 2023-07-25
$56.00
+7.70%
Credit Suisse
Reiterated · Outperform · 2023-04-21
$37.00
−28.80%
Cowen & Co.
Reiterated · Market Perform · 2023-01-26
$37.00
−28.80%
Deutsche Bank
Reiterated · Buy · 2022-11-29
$59.00
+13.50%
TD Securities
Downgraded · Buy → Hold · 2022-04-18
—
—
Atlantic Equities
Upgraded · Neutral → Overweight · 2020-09-23
—
—
CFRA
Reiterated · Buy · 2020-04-23
—
—
Bank of America
Reiterated · Buy · 2019-10-17
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2019-03-06
$54.00
+3.90%
Argus
Upgraded · Hold → Buy · 2018-05-05
—
—
Scotiabank
Downgraded · Sector Outperform → Sector Perform · 2018-01-12
—
—
Avondale Partners
Reiterated · Market Outperform → Outperform · 2017-02-10
—
—
Aegis Capital
Reiterated · Hold · 2016-10-24
—
—
Seaport Global
Reiterated · Neutral · 2016-10-19
—
—
BB&T Capital
Downgraded · Buy → Hold · 2016-07-15
—
—
Oppenheimer
Reiterated · Market Perform → Perform · 2016-06-16
—
—
CLSA
Reiterated · Underperform · 2016-05-19
—
—
Buckingham Research
Reiterated · Buy · 2016-01-14
—
—
Nomura
Reiterated · Buy · 2016-01-14
—
—
Topeka
Reiterated · Hold · 2015-07-10
—
—
Macquarie
Reiterated · Neutral · 2014-08-12
—
—
FBR Capital
Reiterated · Outperform · 2014-06-24
—
—
Deutsche bank
Downgraded · Buy → Hold · 2012-10-18
$59.00
+13.50%
Sterne Agee
Reiterated · Buy · 2012-04-19
—
—
Bank oferica
Reiterated · Buy · 2012-03-15
—
—
One row per institution · price target from the firm's latest published target